Danaher Takes The Lead In The Race To Acquire Abcam – Merger Arbitrage Mondays

Key Highlights

• Abcam (ABCM) to be acquired by Danaher Corporation (DHR) for $5.9 billion.
• The FTC settled with Amgen (AMGN) over its planned acquisition of Horizon (HZNP).
• Diversified Healthcare Trust (DHC) and Office Properties Income Trust (OPI) terminated their merger agreement after facing opposition from multiple parties.

Abcam (ABCM)

Headquartered in Cambridge, U.K., Abcam plc is a life science company, that specializes in the discovery, development, and distribution of reagents and instruments essential for scientific research, diagnostics, and pharmaceutical development.

Established in 1998 by Jonathan Milner, in collaboration with Professor Tony Kouzarides and David Cleevely, the company was conceived with the vision of simplifying the online purchase of antibodies for research scientists.

Only plus or premium subscribers can access this post. Subscribe today.